News
6h
Medpage Today on MSNKennedy's mRNA Moves Anger MAHA Allies; Winning Back NIH Grants; Start-Up Games HSAsMary Talley Bowden, MD, founder of Americans for Health Freedom, an advocacy group that has lobbied against mRNA shots, ...
The race to develop effective cancer vaccines has entered a new phase, with late-stage trials from companies like Moderna ...
Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political ...
A new data analysis, published in Vaccine has found that women and menstruating people who had one or more mRNA-based ...
A fed-batch reaction is harder to design than a batch process because of the need to specify all the variables and quantities.
University of Florida researchers said a new study could lead to a universal cancer shot, while digital health earnings ...
In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...
4h
News-Medical.Net on MSNResearchers develop therapeutic nanoparticles beyond deliveryA group of University of Ottawa researchers have already shown how scientists can harness gene therapies to deliver ...
The degree of waveform distortion in clock genes could be a biomarker to help understand sleep disorders or the effects of aging on our internal clocks.
Analysis of Nucleic Acid Extraction System Market Covering 30 Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GC ...
11h
GlobalData on MSNDiakonos initiates dosing in Phase II trial of glioblastoma treatmentDiakonos Oncology has dosed the first subject in its Phase II trial of investigational patient-derived double-loaded dendritic cell therapy, DOC1021, for treating a highly aggressive brain tumour, ...
23hon MSN
Researchers led by Gen Kurosawa at the RIKEN Center for Interdisciplinary Theoretical and Mathematical Sciences (iTHEMS) in Japan have used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results